SeeThruEquity Issues Update Note on Innovus Pharmaceuticals, Inc. with a Target Price of $0.80 (OTCBB:INNV)
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company note on Innovus Pharmaceuticals, Inc. (OTCBB:INNV)
View full press release